Department of Hematology and Medical Oncology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
BMC Endocr Disord. 2022 Apr 20;22(1):105. doi: 10.1186/s12902-022-01016-4.
Neuroendocrine neoplasms are rare disease and could originate from throughout the body, however, there have been little epidemiological studies in Japan, especially the organ distribution. This study was to examine the epidemiological information of neuroendocrine neoplasms in the Japanese population using data from a hospital-based cancer registry.
Using data from the national database of hospital-based cancer registries, we examined the organ distribution, the stage and initial treatment of neuroendocrine neoplasms newly diagnosed and treated in designated and non-designated cancer care hospitals between 2009 and 2015. In the present study, neuroendocrine neoplasms consisted of neuroendocrine tumors and carcinoma.
A total of 33,215 (17,485 neuroendocrine carcinomas and 15,730 neuroendocrine tumors) cases were diagnosed. The majority in neuroendocrine carcinoma occur in lung (31.1%) followed in decreasing frequency by stomach (12.9%), pancreas (7.5%), rectum (6.7%) and esophagus (5.8%). On the other hand, the half of neuroendocrine tumor originated rectum (50.9%) and followed by pancreas (13.9%), duodenum (9.0%), lung/bronchus (8.9%), and stomach (8.7%). Neuroendocrine carcinoma presented at more advanced stage and higher age than neuroendocrine tumors. Most cases of neuroendocrine tumors were treated surgically, while half of neuroendocrine carcinomas were treated with non-surgical therapy consisting of chemotherapy with or without radiotherapy.
Our results demonstrated that neuroendocrine neoplasms could originate from various organs and the site distribution was different between neuroendocrine carcinoma and tumor. The national database of hospital-based cancer registries in Japan is a valuable source for evaluating the organ distribution of the rare systemic disease.
神经内分泌肿瘤是一种罕见疾病,可能起源于全身各处,但在日本,此类疾病的流行病学研究较少,特别是关于器官分布的研究。本研究旨在利用医院癌症登记数据库中的数据,研究日本人群中神经内分泌肿瘤的流行病学信息。
利用国家医院癌症登记数据库的数据,我们分析了 2009 年至 2015 年间在指定和非指定癌症治疗医院新诊断和治疗的神经内分泌肿瘤的器官分布、分期和初始治疗。在本研究中,神经内分泌肿瘤包括神经内分泌癌和神经内分泌瘤。
共诊断出 33215 例(17485 例神经内分泌癌和 15730 例神经内分泌瘤)。神经内分泌癌中,大多数发生于肺部(31.1%),其次是胃(12.9%)、胰腺(7.5%)、直肠(6.7%)和食管(5.8%)。另一方面,神经内分泌瘤有一半起源于直肠(50.9%),其次是胰腺(13.9%)、十二指肠(9.0%)、肺/支气管(8.9%)和胃(8.7%)。神经内分泌癌的分期和年龄均高于神经内分泌瘤。大多数神经内分泌瘤患者接受手术治疗,而一半的神经内分泌癌患者接受非手术治疗,包括化疗联合或不联合放疗。
我们的研究结果表明,神经内分泌肿瘤可能起源于多个器官,且神经内分泌癌和瘤之间的发病部位分布不同。日本医院癌症登记数据库是评估罕见系统性疾病器官分布的有价值资源。